Compare KRYS & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | IDCC |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.9B |
| IPO Year | 2017 | 2007 |
| Metric | KRYS | IDCC |
|---|---|---|
| Price | $259.27 | $364.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $297.60 | ★ $412.50 |
| AVG Volume (30 Days) | ★ 260.4K | 237.5K |
| Earning Date | 05-18-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | 6.84 | ★ 11.80 |
| Revenue | ★ $389,130,000.00 | $307,404,000.00 |
| Revenue This Year | $40.88 | N/A |
| Revenue Next Year | $35.16 | $3.38 |
| P/E Ratio | $37.15 | ★ $30.38 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $180.60 |
| 52 Week High | $298.30 | $412.60 |
| Indicator | KRYS | IDCC |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 52.15 |
| Support Level | $255.65 | $353.39 |
| Resistance Level | $293.60 | $363.73 |
| Average True Range (ATR) | 11.12 | 16.10 |
| MACD | -2.10 | -1.73 |
| Stochastic Oscillator | 20.44 | 49.11 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.